Putting non-alcoholic fatty liver disease on the radar for primary care physicians: how well are we doing?

por Sanyal, Arun J.
Publicado 2018

Recent advances in understanding/management of non-alcoholic steatohepatitis

por Pacana, Tommy, Sanyal, Arun J.
Publicado 2015

Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis

por Albhaisi, Somaya, Sanyal, Arun J.
Publicado 2021

The use of cell free DNA in the diagnosis of HCC

por Banini, Bubu A., Sanyal, Arun J.
Publicado 2019

Fibrosis-4 index is associated with the risk of hepatocellular carcinoma in patients with cirrhosis and nonalcoholic steatohepatitis

por Albhaisi, Somaya, Sun, Jing, Sanyal, Arun J.
Publicado 2023

Non-alcoholic fatty liver disease in lean individuals

por Albhaisi, Somaya, Chowdhury, Abhijit, Sanyal, Arun J.
Publicado 2019

Drug discovery and treatment paradigms in nonalcoholic steatohepatitis

por Noureddin, Mazen, Muthiah, Mark D., Sanyal, Arun J.
Publicado 2019

Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review

por Cariou, Bertrand, Byrne, Christopher D., Loomba, Rohit, Sanyal, Arun J.
Publicado 2021

Metabolomic Profiling to Identify Predictors of Response to Vitamin E for Non-Alcoholic Steatohepatitis (NASH)

por Cheng, Jianfeng, Joyce, Andrew, Yates, Katherine, Aouizerat, Bradley, Sanyal, Arun J.
Publicado 2012

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

por Estes, Chris, Razavi, Homie, Loomba, Rohit, Younossi, Zobair, Sanyal, Arun J.
Publicado 2017

Rifaximin has the potential to prevent complications of cirrhosis

por Flamm, Steven L., Mullen, Kevin D., Heimanson, Zeev, Sanyal, Arun J.
Publicado 2018

Harnessing Muscle–Liver Crosstalk to Treat Nonalcoholic Steatohepatitis

por Chakravarthy, Manu V., Siddiqui, Mohammad S., Forsgren, Mikael F., Sanyal, Arun J.
Publicado 2020

Nonalcoholic fatty liver disease is specifically related to the risk of hepatocellular cancer but not extrahepatic malignancies

por Albhaisi, Somaya, McClish, Donna, Kang, Le, Gal, Tamas, Sanyal, Arun J.
Publicado 2022

Adverse muscle composition is a significant risk factor for all-cause mortality in NAFLD

por Linge, Jennifer, Nasr, Patrik, Sanyal, Arun J., Dahlqvist Leinhard, Olof, Ekstedt, Mattias
Publicado 2022

Adverse muscle composition predicts all‐cause mortality in the UK Biobank imaging study

por Linge, Jennifer, Petersson, Mikael, Forsgren, Mikael F., Sanyal, Arun J., Dahlqvist Leinhard, Olof
Publicado 2021

Reduction in acute kidney injury stage predicts survival in patients with type-1 hepatorenal syndrome

por Wong, Florence, Boyer, Thomas D, Sanyal, Arun J, Pappas, Stephen C, Escalante, Shannon, Jamil, Khurram
Publicado 2019

Review article: the impact of liver‐directed therapies on the atherogenic risk profile in non‐alcoholic steatohepatitis

por Connelly, Margery A., Velez Rivera, Jonathan, Guyton, John R., Siddiqui, Mohammad Shadab, Sanyal, Arun J.
Publicado 2020

Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals

por Noureddin, Mazen, Wong, Micaela M, Todo, Tsuyoshi, Lu, Shelly C, Sanyal, Arun J, Mena, Edward A
Publicado 2018

LPCN 1144 Resolves NAFLD in Hypogonadal Males

por Albhaisi, Somaya, Kim, Kilyoung, Baker, Jonathan, Chidambaram, Nachiappan, Patel, Mahesh V., Charlton, Michael, Sanyal, Arun J.
Publicado 2020

NIS2+™, an effective blood-based test for the diagnosis of at-risk nonalcoholic steatohepatitis in adults 65 years and older

por Sanyal, Arun J., Magnanensi, Jérémy, Majd, Zouher, Rosenquist, Christian, Vera, Delphis M., Almas, James P., Connelly, Margery A.
Publicado 2023